ANZMES speaks to parliament

Today, May 3rd the Associated New Zealand Myalgic Encephalomyelitis Society Incorporated provided an oral submission to the Health Select Committee, which was live streamed.

You can watch it here:

This video on YouTube features only the section of proceedings that relates to the ANZMES petition and oral submission. Watch the full video on the Health Select Committee’s Facebook page (with ANZMES submission at minute 39:10): https://fb.watch/khpmwwAaJR/. This video has been shortened for YouTube with permission obtained by the administration of the Health Select Committee.

Due out next week, for ME/CFS Awareness month, is a special episode of Know M.E. video podcast featuring ANZMES president Fiona Charlton, Executive Committee Member Wendy Matthews, Emeritus Professor Warren Tate, and RNZCGP’s Fellow Dr. Sarah Dalziel. These four discuss the oral presentation, how they think it went, and what we hope to achieve through this petition and consideration by the Health Select Committee.

The speech by ANZMES is presented here:

Tena katou katoa. Members of parliament, thank you for the opportunity to present further testimony in support of our petition. I am Fiona Charlton, president of ANZMES and I’m joined today by Emeritus Professor Warren Tate and RNZCGPs Fellow Dr. Sarah Dalziel who can answer your questions.

We understand that you have invited representatives from Whaikaha and Ministry of Health to also speak today.

In the written submission by Whaikaha, they recognise that ME fits the criteria for disability. But the responsibility lies with other government agencies to provide services. There is nothing dedicated to the unique needs of pwME.

The Ministry of Health states that the system doesn’t require people with ME (pwME) to be classed with a disability to access services. This unfortunately lacks understanding of what happens in practice, what pwME experience when trying to access services, and what the reclassification would mean for pwME. We invite representatives to meet with us to discuss ways in which the government can better support pwME.

Key points for you to please understand and consider:

  • ME is a disability. Post Exertional Malaise – the cardinal symptom of ME causes symptom exacerbation which is often misunderstood and makes levels of disability difficult to assess without adequate knowledge and education of the condition.
  • When you understand PEM you understand that pwME have to choose between making a meal and attending an appointment outside of the home. They have to choose between taking a shower and doing laundry. It is a constant battle between tasks and the energy capacity to function enough to carry out those tasks.
  • ME is a disability because of this energy limited capacity. It is a condition that impairs the ability to function on a regular basis both cognitively and physically and this frequently confines people to their home and beds, causing unemployment and an inability to perform basic tasks of daily life.
  • ME/CFS is a disability. There is no known cure. For many it is lifelong.
  • ME is a disability. It fits the definition, Whaikaha has also submitted that ME fits the definition. 
  • The United Nations report to the government recommends that people with ME/CFS should have access to the disability support system and be included in disability policies and programs.

We created this petition to draw attention to the fact that the system is not working for pwME. Many fall through the cracks, many rely on whanau to care for them. Those who aren’t lucky enough to have family to care for them, experience PEM crashes regularly just trying to make a meal or do laundry. This means they’re in a constant state of unwellness.

  • Yet the eligibility criteria are inconsistent throughout the country resulting in a postcode lottery for health care. Besides the direct practical ramifications of this, it is a health equity issue.
  • The inconsistent criteria mean that in practice, the majority of pwME are unable to access services that the Ministry of Health state is available.
  • People with ME are theoretically entitled to support under the chronic illness classification, however they’re NOT receiving it in practice.
  • The Needs Assessment and Service Coordination (NASC) organisation who assess home help eligibility confirm that ME patients are NOT considered for assessment. The closest equivalent disease, Multiple Sclerosis (MS), is accepted for assessment, despite evidence that MS has lower prevalence and less associated functional disability than ME.
  • The vast majority of pwME do not meet the criteria for home help under the Long Term Support – Chronic Health Conditions designation. Which is targeted at the over 65, those with very high needs, or for conditions such as diabetes.
  • Even those with ME with very high needs that do meet the criteria, get insufficient care and the care role falls to family. For example a 22 year old with severe ME who is bed bound, unable to feed herself, unable to toilet herself, bathe herself, she’s unable to speak and on a liquid diet. She’s unable to leave her darkened room due to extreme sensitivities to light, sound, touch. Her mother is now her fulltime carer, leaving her nursing job, reducing the family’s income, yet they’ve only been granted 22 hours of care per week from an outside professional and currently only 11 hours of this can be supplied due to staff shortages. That mother, who has given up paid employment to care for her daughter, is only given 11 hours break per week.

We call for standardised nationwide criteria and policies that recognise the severely debilitating nature of this condition.
We call for funding. Currently there is no dedicated funding invested by the government for the wellbeing of people with ME/CFS, including no funding for research, despite its increasing prevalence.

In 2012 the Health Select Committee recommended the reclassification of ME to disability to the government after hearing our first petition. This recommendation was not implemented by the government.

We urge you to also make this recommendation, but be active in ensuring this results in real, practical change for pwME. With recognition and access to services they deserve.

Early intervention promotes recovery. Access to support promotes improved outcomes. It can help prevent further disability, further worsening of the condition which often requires hospitalisation. Access to home help enables a person with ME to potentially do a work from home job, if they can choose to use their limited energy on paid employment rather than making a meal, doing laundry, getting the children off to school with a packed lunch.

It’s not just about home help. 

Being classified as a disability demonstrates the government understands how truly disabling this condition is. It legitimises ME and provides protection of rights as a disabled person. It will enable them to fit into the criteria for NASC assessment and home help services.

We recognise that the government has done some work for people with long COVID (LC). The advisory produced guidelines. There are long COVID clinics getting ready to open in 4 main regions of Aotearoa. But people experiencing PEM (which those with LC do just like pwME) will find it very difficult to make it to appointments. ANZMES and Complex Chronic Illness Support and other ME organisations have the solutions. We’re already helping pwLC and ME, so come to the table and discuss with us how best to supply the services required. We have the lived experience, the knowledge, and the expertise.

A change in classification would be a lifeline to dedicated support and wider acknowledgement that their illness is disabling, providing fairer access to established support and care. 

We urge you to stand with us and help pwME.

Photo Credit: Action for ME
Photo Credit: Martyna Reynolds

If ANZMES had more than the allotted 10 minutes, we would have made more valid points such as:

The criteria for Home Help currently exclude pwME as sufficiently disabled, despite significant disease burden and limited functionality.

In order to be diagnosed with ME/CFS a person must be significantly impaired in terms of functioning in daily life, such as work or school, however the condition fluctuates in severity, with periods of remission and relapse.

ME is widely misunderstood: despite the increasing awareness and research proving the biomedical basis of the illness it is still often dismissed as a psychological condition or malingering, resulting in a lack of support from society and official support networks – further compounding the disability.

The most fundamental insight from research into ME/CFS and now also Long COVID is our understanding of Post Exertional Malaise and the importance of pacing. When supported adequately and no longer pushing through symptoms, people are able to prevent their illness from worsening and this approach is now part of best practice health care recommendations. Many doctors, welfare assessors, insurance assessors don’t adequately understand PEM, leading to denial of needed services or financial support and may demand pwME undertake ineffective or harmful therapies.  Education is key here but this is a long-term strategy and a disability classification would send a strong signal and help people right now.

The World Health Organisation’s International Classification of Functioning, Disability, and Health (ICF) model establishes three levels of human functioning: (1) at the level of body or body part (body structures and functions domain), (2) the whole person (activities domain), and (3) the whole person considered in a social context (participation domain). In this classification, disability implies a certain degree of dysfunction at one or more of these same levels: impairments, activity limitations, and participation restrictions, respectively. 

ME/CFS meets all levels of this definition of disability and in fact meets all definitions including those of the New Zealand government.  Several symptoms contribute to disability for people with ME/CFS including fatigue, cognitive dysfunction, pain, sleep disturbance, post exertional malaise and autonomic dysfunction. These can have a significant impact on daily life, for example dysfunction of the autonomic nervous system can mean that a person is dizzy or faints when they go from sitting to standing. 

An estimated 40,000 people suffer with ME/CFS in NZ and now we add to this 30,000 with unresolving long COVID. 

Our surveys show that despite the fact that at least 25% of people with ME/CFS are severely ill and bedridden and 60% are severely debilitated and housebound, they are unable to access funded care set out for this kind of disability, even when their doctor has referred them. 

Our surveys also show that people with ME/CFS, in NZ, feel ignored, isolated and their quality of life is low and this is largely due to a lack of support.

Quality of life is significantly lower compared with conditions such as cancer, depression, heart disease, diabetes, and rheumatoid arthritis. Many of these conditions have larger funding pools and patients can often more easily access home help.

A disability research programme in the UK, known as DRILL, found that “people with a wide range of different diagnoses share a lived experience of chronic illness that goes far beyond ‘fatigue’.” The research group developed the term ‘energy impairment’ to describe this experience and Energy Limiting Conditions as a broad cohort that experience disability. They include Fibromyalgia, a range of neurological, musculoskeletal, auto-immune and respiratory diseases. Their work is worth reading to gain insight into their perspective on the experience of energy impairment as a disability, in particular they state that fatigue is seen as being at the bottom of the disability hierarchy despite being very impactful on day to day activities like showering. For people with energy impairment, inequalities stem from this kind of attitude and practice of disbelief and invalidation that diminishes their lives.

ANZMES has provided a written report (to accompany the petition) with a series of solutions, which begins with reclassification and includes dedicated funding, a contract for wraparound services and the creation of a tailored support structure with a tiered system that recognises the varying degrees of disability experienced by people with ME/CFS. We also recommend that we align our health care approach with the latest research and recommendations by implementing a multi-disciplinary pilot.

From a person with ME/CFS:
Getting up to the bathroom feels like a marathon. Every part of my body hurts and I feel as if my limbs are weighed down by something. My thoughts are clouded and escape me like they are lost in a thick fog. Today, I will choose between having a shower and making a meal before my legs give way altogether. The chores pile up around me and I feel as though I am being swallowed alive by this illness. I watch life pass me by in a blur and cling to the hope that tomorrow will be better.

Together we stand and ask to be seen, to be heard, and to finally be supported.

Home help is declined for an individual with impairments, if there is a family member who can do the chores for them. This means that family members have to take on care roles, instead of a professional coming into the home to carry out those duties. It changes the family dynamic when someone, usually unqualified in healthcare, has to bathe a family member, cook for them, help them to the toilet, or to the lounge because they can’t walk unaided.

When asked by the Health Select Committee if reclassifying would help people with ME/CFS, Whaikaha representatives stated that it would enable pwME to gain access to services, such as home help support. Martin Chadwick, Ministry of Health representative also stated that reclassification would enable NASC assessments and recognition for the condition.

We look forward to due consideration by the Health Select Committee and await their report, in which, we hope that they make the recommendation to reclassify ME/CFS as a disability, and put forward the solutions that ANZMES have presented. This is the first step. It is then up to the government to implement the recommendations, and this step is long over due.

ME/CFS Reclassification Petition – ANZMES set to speak to parliament

ANZMES is set to speak to parliament on May 3rd to present an oral submission to the Health Committee – an opportunity to strengthen the argument for the reclassification of ME/CFS to a disability.

Associated New Zealand Myalgic Encephalomyelitis Society (ANZMES) petition to reclassify ME/CFS as a disability was read in Parliament, on the 13th of September 2022, and has been under consideration with the Health Committee since then.

ANZMES president, Fiona Charlton, will speak to parliament on behalf of the members that she represents, along with Emeritus Professor Warren Tate and RCNZGPs Fellow Dr. Sarah Dalziel, who will answer the committee’s questions.

ME/CFS is a debilitating long term condition that affects multiple body systems and is characterised by Post Exertional Malaise, where symptoms worsen after periods of even ordinary activities. The current classification of ME/CFS as an illness rather than a disability makes it difficult for individuals who suffer from the condition to access the necessary support that they need to lead quality lives.

“We must make this chronic condition a disability now and give people fair access to the help that they need,” says Charlton.

A growing number of people with long COVID are now being diagnosed with ME/CFS, putting strain on already exhausted resources.

There is no dedicated funding for the condition and the current classification and system is difficult to navigate. There are complicated assessment processes and policies. There is disparity between regions causing access inequality.

In order to be diagnosed with ME/CFS a person must be significantly impaired in terms of functioning in daily life, such as work or school.

ANZMES has presented the government with detailed reports, research and recommendations and now hope that they will listen and take the urgent action that is needed.

Reclassification will lead to real improvements for those in need; providing access to disability support services – much needed home help, housing support, financial support, and counselling access.


What is ME/CFS?

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is often triggered by a viral illness and involves overwhelming fatigue and other symptoms that range in severity as it affects many body systems, such as the immune, neuroendocrine and autonomic nervous system.

The key characteristic of ME/CFS is post exertional malaise (PEM) which presents 12-48 hours after exertion, and can result in days to weeks of exacerbated symptoms. For the very severe, this exertion can be simply trying to speak, or eat.

Who are ANZMES?

The Associated New Zealand Society for ME/CFS (ANZMES) have been providing information, awareness for ME/CFS, funding research, and advocating for people with ME/CFS for the past 43 years (since 1980). As the national advisory body for ME/CFS in New Zealand, ANZMES disseminates evidence-based information nationally, and represents the ME/CFS voice globally as a founding member of the World ME Alliance. ANZMES acts as the voice of all people living with this disabling disease through advocacy and leadership. ANZMES is a RNZCGP registered provider for continuing education. Health professionals can earn CME/CPD credits with ANZMES latest education programme – Know M.E. – a video podcast and news series featuring up-to-date, evidence based research and information on ME/CFS and Post COVID Conditions.


For more information contact

info@anzmes.org.nz

Petition: Reclassify ME/CFS to Disability

Join us

Associated New Zealand Myalgic Encephalomyelitis Society (ANZMES) is calling for ME/CFS to be reclassified as a disability.

We urge you to to pledge your support for this change.

People with this debilitating condition face a barrier to support under the current classification of “chronic illness” and as a result experience poor quality of life and health inequity. With increasing numbers of people with Long COVID (LC) being diagnosed with ME/CFS the existing support through nonprofit organisations is set to become unmanageable, with case numbers still rising.

With the new Whaikaha – Ministry of Disabled People still in development ANZMES sees that this is a timely opportunity to move forward with this long overdue change.

ANZMES President, Fiona Charlton says, “it is vital for ME/CFS and LC that this access is improved. “Many people have symptoms that are so severe that they struggle with daily tasks like showering, making a meal and are bedbound or require a wheelchair. “This growing community of chronically ill people deserve better treatment and urgently need more access to financial support and health services with acknowledgment that their illness is disabling.”

Photo Credit: Martyna Reynolds
Photo Credit: 123rf

Despite the symptoms of ME/CFS meeting many of the definitions for disability, the illness is not categorised as a disability in New Zealand for the purpose of health-related funding and support.

The Human Rights Act 1993 states that disability can be defined as:

Physical disability or impairment: physical illness: psychiatric illness: intellectual or psychological
disability or impairment: any other loss or abnormality of psychological, physiological: or anatomical
structure or function: reliance on a guide dog, wheelchair, or other remedial means: the presence in the
body of organisms capable of causing illness.

Reclassification will lead to real improvements in quality of life for those in need. Some people with ME/CFS become ill and never return to their pre-illness capabilities – this makes the condition life-long. ME/CFS patients require home help, housing support, financial support, and counselling access. Many people, following COVID-19 infection, are being diagnosed with ME/CFS and also require ongoing support services.

Photo Credit: FitnessForThisAbility.com
Photo Credit: Glide.com.au

Reclassification of ME/CFS to disability would result in:

  • legitimisation and validation of a person living with ME/CFS as a disabled person, and a protection of their rights as a disabled person,
  • easier access to governmental financial support and ministry services,
  • increased access to social services,
  • access to need assessments as a recognised disabled person,
  • access to home-help support and services, including mobility aids, and grants for home modifications for wheelchair use,
  • access to free immunisations on a voluntary basis,
  • increased level of care and support through social services and educational institutions.


What is ME/CFS?
A chronic illness involving overwhelming ongoing fatigue, ME/CFS is often triggered by a viral illness. The condition causes a variety of symptoms that range in severity as it affects many body systems, such as the immune, neuroendocrine and autonomic nervous system.

Who are ANZMES?
ANZMES has been providing information, building awareness, funding research, and advocating for people with ME/CFS for the past 42 years (since 1980). As the national advisory body for ME/CFS in New Zealand, ANZMES disseminates evidence-based information nationally, and represents the ME/CFS voice globally as a founding member of the World ME Alliance. ANZMES acts as the voice of all people living with this disabling disease through advocacy and leadership.

ANZMES urges you to join us in supporting this petition by signing and sharing with your networks: https://www.parliament.nz/en/pb/petitions/document/PET_125649/petition-of-associated-myalgic-encephalomyelitis-society

ANZMES backs World ME Alliance position

– no endorsement for Lightning Process for ME

The Associated New Zealand Myalgic Encephalomyelitis Society (ANZMES) supports the new position paper on the Lightning Process by the World ME Alliance and does not endorse the Lightning Process for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). 

The Lightning Process is a programme loosely based on concepts of neuro linguistic programming (NLP) and cognitive behaviour therapy (CBT) that is set up commercially and currently marketed as a cure for ME/CFS. This claim is not backed by scientific evidence and ANZMES shares the view of the World ME Alliance that the promotion of this programme is likely to do harm.

The National Institute for Health and Care Excellence (NICE), in the UK, revised their guidelines for the diagnosis, treatment, and management of ME/CFS stating that the lightning process should not be used as a treatment and they no longer recommend CBT. These changes reflect a shift from an outdated perspective that ME/CFS was a psychological condition and follows evidence from over 200 studies showing poor efficacy for this treatment approach.

ANZMES President, Fiona Charlton says, “there is a growing body of evidence that shows that ME is driven by physiological changes not psychological ones and telling people that they can talk themselves out of this condition, within three days, could be very harmful.

“We know that if people with ME ignore their symptoms and push themselves this can make things worse, sometimes to the point of needing hospital care.”

ANZMES agrees with the World ME Alliance who highlight in their statement that people with ME/CFS are vulnerable to exploitation due to a lack of effective treatment where programmes like the Lightning Process are just filling this void.

People living with Long COVID are also being drawn into this treatment as this is now an extension of their claims to cure ME/CFS.

Other concerns with the Lightning Process include a bias in efficacy studies, including conflicts of interest, a reported secrecy where participants are told not to speak about the programme or their symptoms and a level of shame and guilt for those who do not recover within the three days of treatment.

Charlton says, “we want to ensure that if we are endorsing a treatment for ME that robust evidence supports efficacy and this is just not the case with LP. 

“What we do know is that a treatment approach that is focussed around symptom management is shown to help with the relapsing nature of ME.”

ANZMES acknowledges that neurological symptoms, such as depression and anxiety can be a part of ME/CFS and may benefit from supportive therapies but people have the right to unbiased, impartial information when being offered these treatments.

***********************

The Lightning Process was developed and trademarked by British osteopath and hypnotherapist Phil Parker.

ANZMES has been providing information, building awareness, funding research, and advocating for people with ME/CFS for the past 42 years (since 1980). As the national advisory body for ME/CFS in New Zealand, ANZMES disseminates evidence-based information nationally, and represents the ME/CFS voice, globally as a founding member of the World ME Alliance. ANZMES acts as the voice of all people living with this disabling disease through advocacy and leadership.

Position Statement World ME Alliance

NICE Guidelines

Contact ANZMES for more information

First World ME Day

image of the world from space, with text The first ever World ME Day May 12th 2022
worldmeday.org

First World ME Day and theme launched by alliance members

The World ME Alliance, a collaborative of organisations from across the globe, is launching World ME Day on 12th May this year. This new initiative aims to bring together organisations and unify efforts to raise awareness and campaign together on Myalgic Encephalomyelitis (ME). Through collective action, we will step closer to our goal of a world without ME.

World ME Day will build on the incredible efforts of advocates around events, such as ME Awareness Week and Chronic Immunological and Neurological Diseases (CIND) Awareness Day. By focusing on a single day and collaborating across many organisations, we aim to maximise our collective power.

The theme for the first year of World ME Day is #LearnFromME.

Read More: here

image of a lightbulb inside a chalk drawing of a thought bubble with the text #learnfromme world me day

What should the world #LearnFromME?

ME is a global health crisis – up to 30 million people are living with this disease worldwide, and when we take into account the effect on families, carers and friends too, the impact of this disease cannot be overstated.

But there is much to be learnt from this disease – from the willpower and determination of those living with it, to the incredible advocates working towards change, to an understanding that the most meaningful change will comes from high-quality research.

We want to use World ME Day to reach out to health professionals on a personal basis, build understanding of ME and take another step towards a world that understands ME.

Key facts for health professionals

  • People with ME have a lower average quality of life than all other diseases they have been compared to, including diabetes, cancers and heart disease.

Read more: here

ANZMES STATEMENT LIGHTNING PROCESS 13 October 2021

There are some therapies which are commercially based, and they come under many names. Lightning Process is one that has been widely known. This is a psychological approach based on neurolinguistic programming, a technique that may have benefits for those who are experiencing depression or anxiety.

Claims have been made that the Lightning Process is a cure and some have said it did cure or significantly help them, but as yet no scientific trials have been done with a group selected from stringent ME/CFS or Long COVID research guidelines. It is possible responders may have conditions other than ME/CFS or Long COVID.

We are concerned by its promotion of it as a ‘cure’ for ME/CFS and Long COVID. At present this is not scientifically proven. We have received reports from those who have spent a great deal of money to try this or similar treatments who have made no improvement, have not been cured or have relapsed severely. The guilt experienced by those who are not cured can be devastating.

On 27 September 2017, the ME Association in the UK published this article on their website:
https://meassociation.org.uk/2017/09/me-association-statement-lightning-process-and-smile-trial-in-young-people-with-mecfs-19-september-2017/

The following is a quote from Dr Charles Shepherd, medical advisor to the ME Association:
“‘The Lightning Process’ is not a treatment that we endorse or recommend for people with ME/CFS. “Patient evidence, gathered from our members over many years, indicates that some people who have gone through the LP try to make rapid and unrealistic improvements in their physical and mental activity levels. However, this is followed by a relapse or significant worsening of symptoms. Others who have gone through the LP programme report that they have spent huge amounts of money with no obvious benefit. It may well be that there are some people with a general fatigue state, resulting from stress, emotional or psychological problems who could benefit from a ‘mind over matter’ entity and not to be confused with ME/CFS. There has been a very significant growth in biomedical research globally into M.E. in the past decade. This over-simplistic and largely psychological model of ME/CFS causation that is being put forward to patients is totally out of step with emerging scientific evidence as to the cause of ME/CFS.”

Since Dr Shepherd wrote this statement, there has been even more robust scientific research into ME/CFS as a neuro-inflammatory disease. One might do well to remember that multiple sclerosis was once seen as a kind of ‘hysteria,’ until MRI machines were able to identify the lesions associated with this disease on the myelin sheath. Research into the biomedical causes and potential treatments of ME/CFS and Long COVID is proceeding at a rapid rate and new therapies are being developed, including the possibility of treatment through using existing medications.

Along with providing support, it is the aim of ANZMES to provide sufferers of ME/CFS and Long COVID with accurate and up-to-date medical information. We encourage all patients, medical practitioners, family members or the general public to contact us with any questions you may have.

Associated Myalgic Encephalomyelitis Society of New Zealand, Inc.

Update – National Institute for Health and Care Excellence (UK) published revised guidelines on October 29, 2021. In this revision, NICE stated that the Lightning Process should not be offered as a treatment for people with ME/CFS (point 1.12.27 of the recommendations) as it could potentially cause harm. For more information visit: https://www.nice.org.uk/guidance/ng206/chapter/Recommendations 

Doctor Ros Vallings at the Public Meeting in Dunedin Colquoun Theatre 22 Sept, 2014.

Ros trip
Dr Vallings being introduced at the meeting.

Ros2
Dr Ros Vallings lecturing to the crowd.

Debbie
Debbie, ANZMES manager with resources ready to give out.

Doctor Ros Vallings lectured at the Colquhoun Theater in Dunedin on the 22nd September, 2014 to make a Podcast for Medical Students education at a public meeting.
Resources were given to Doctors and Medical Students who attended plus members of the public. There were over a large crowd who turned up on a cold snowy day to listen to the latest information from Ros.

ANZMES AGM 2nd November 2014

Australian Paediatrician Kathy Rowe
Australian Paediatrician Kathy Rowe

ANZMES AGM will be held on the 2nd November at 1pm at the CCS resource Centre in Royal Oak. Guest Speaker will be Dr Kathy Rowe a top Australian Paediatrician. After the AGM Kathy will be visiting many New Zealand main centres to lecture to paediatricians and Medical professionals.

Over the past 44 years, Kathy Rowe has achieved outstanding national and international recognition for her work in adolescent health. She is widely acclaimed as a caring, dedicated consultant physician, in the Centre for Adolescent Health at Melbourne’s Royal Children’s Hospital. She has also held academic appointments in the University of Melbourne’s Department of Paediatrics, involved in teaching, research and clinical work.

She is an expert in the area of chronic fatigue syndrome, having worked tirelessly and championed its cause when it was not fashionable. Prof Leonard Jason referred to her work as “the most elegant and important in the field” and stated that “the entire field has benefited from the precision and rigor of her methods.”She worked hard on the international committee establishing the paediatric case definition and diagnostic criteria for CFS/ME (2006).

ME Day

ME/CFS day is on the 12th of May.
This date was picked as it was the anniversary of Florence Nightingales Birthday.
Florence was thought to have had ME/CFS in the later  years of her life.
To celebrate ME day ANZMES has sent resources including latest Physicians booklets
Childrens Booklets and posters etc to all the Support Group through NZ.

An ANZMES survey of how ME/CFS impacts on sufferers has been compiled and thanks to Don Baken for his help with this. Massey University has helped with a media release of the survey.
Dr Ros Vallings is speaking on Monday Morning on TV about ME/CFS and the ANZMES survey.
Articles are in local newspapers that have been put in by support groups up and down NZ.
Here are some articles from the ME day release.

Phoenix Rising

Malcare WordPress Security